Overview

An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder

Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Radafaxine in Patients with Major Depressive Disorder (MDD)
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline